(IN BRIEF) Eckert & Ziegler successfully hosted the 3rd annual Boston Radionuclide Theranostics Forum, bringing together industry leaders to discuss radionuclide theranostics’ role in transforming precision oncology. The event featured expert presentations on advancements in radiopharmaceuticals, clinical development challenges, and … Read the full press release
Posted in Berlin, Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Technology
Tagged Boston Radionuclide Theranostics Forum, clinical development, Dr. Harald Hasselmann, Eckert & Ziegler, German American Business Council, Industry innovation, Morrison Foerster, nuclear medicine, patient access, precision oncology, radionuclide theranostics, radiopharmaceutical community, radiopharmaceuticals, radiotherapy, Solomon Partners
(IN BRIEF) Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing on advancements in kidney care, artificial intelligence, fluid management, and hemodiafiltration. Key studies include the … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology
Tagged AI, Andrea Nandorine Ban, artificial intelligence, CONVINCE trial, dialysis, ERA Congress, fluid management, Frank Maddux, Fresenius Medical Care, hemodiafiltration, hemodialysis, kidney disease, medical advancements, nephrology, patient outcomes, Renal Research Institute, RESEARCH
(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Bruton’s tyrosine kinase, BTK inhibitor, clinical data, clinical research, clinical trial, data, disability, disability progression, fenebrutinib, FENopta, Levi Garraway, multiple sclerosis, Phase II, relapse rates, relapsing multiple sclerosis, RMS, Roche, treatment
(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged adverse events, AERIFY-1, AERIFY-2, Chronic obstructive pulmonary disease, clinical trials, COPD, COVID-19, drug efficacy, Exacerbations, IL33, Itepekimab, moderate exacerbations, monoclonal antibody, partnership, phase 3 study, Regeneron, regulatory authorities, research and development, Sanofi, severe exacerbations, therapeutic development
(IN BRIEF) NHS Lanarkshire and the University of Glasgow have formalized a Strategic Partnership Agreement to transform healthcare delivery, advance clinical research, and improve health outcomes across Lanarkshire. This collaboration will focus on reducing health inequalities, enhancing patient care, and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Investment, Management, Marketing, News, Technology, United Kingdom
Tagged clinical research, clinical trials, collaboration, health outcomes, healthcare delivery, Healthcare Innovation, Lanarkshire, NHS Lanarkshire, partnership, patient care, reducing health inequalities, staff development, strategic partnership, teaching and research, University of Glasgow
(IN BRIEF) A new study by Unilever, in collaboration with the University of Liverpool, has revealed a potential link between the skin microbiome and psychological wellbeing. The research found that higher levels of the skin bacterium Cutibacterium, especially on the … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Financial, Healthcare, Industrial, Investment, Management, News, Retail, Science, Technology, United Kingdom
Tagged beauty and wellbeing, beauty products, Cutibacterium, Dermalogica, Dove, mental health, microbiome study, mood improvement, Pond’s, psychological wellbeing, R&D, skin microbiome, skin-brain axis, skincare research, stress reduction, Unilever, University of Liverpool, Vaseline
(IN BRIEF) A team of researchers from the University of Copenhagen has revealed groundbreaking findings about insulin resistance, showing that it varies widely on a molecular level even among healthy individuals and those diagnosed with type 2 diabetes. This discovery … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Anna Krook, Atul Deshmukh, diabetes research, early diagnosis, insulin resistance, Jeppe Kjærgaard Northcote, Karolinska Institutet, molecular signatures, muscle tissue, personalized treatments, precision medicine, proteomics, Steno Diabetes Center, type 2 diabetes, University of Copenhagen
(IN BRIEF) AF Gruppen has been chosen by Helse Sør-Øst RFH to carry out the structural work at the New Rikshospitalet, with a contract valued at NOK 960 million. This comprehensive project includes groundwork, concrete work for foundations, walls, and … Read the full press release
Posted in Business, Construction, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Norway, Technology
Tagged AF Gruppen, Amund Tøftum, concrete work, construction contract, Gaustad, healthcare project, Helse Sør-Øst RFH, hospital development, hospital of the future, New Rikshospitalet, NOK 960 million, partnership, prefabricated structures, structural work
(IN BRIEF) Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid cell engager, which has shown promising results in B-cell depletion, may offer potential breakthroughs in autoimmune diseases, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, antibody therapeutics, autoimmune diseases, B cell depletion, biopharmaceuticals, bispecific myeloid cell engager, clinical-stage, DR-0201, Dren Bio, immunology, lupus, partnership, phagocytosis, Sanofi, SAR448501, therapeutics
(IN BRIEF) TreeFrog Therapeutics has secured €30 million in financing from the European Investment Bank to advance its cell therapy program for Parkinson’s disease and support the development of its internal pipeline targeting diseases with high unmet needs. The funding, … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged 3D microtissues, bioreactors, C-Stem, cell therapy, dilutive financing, EIB, European Investment Bank, Healthcare Innovation, InvestEU, iPSCs, Microfluidics, Parkinson's disease, partnership, Regenerative medicine, stem cell biology, sustainability, TreeFrog Therapeutics, venture debt, €30 million financing
(IN BRIEF) Researchers from the University of Southampton will join the Breast Walk Ever charity event on 8 June 2025 to support Against Breast Cancer and raise funds for vital research into secondary breast cancer. ABC-funded PhD student Grace Hayes … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Science, Society, Technology, United Kingdom
Tagged ABC events, Against Breast Cancer, bone metastasis, Breast Walk Ever, Cancer Detection, cancer research, charity event, Deborah Parnell, fundraising, fundraising event, Grace Hayes, Hursley, immunology, immunotherapy, miONCO test, PhD student research, Richard Martin, secondary breast cancer, Southampton researchers, University of Southampton, Winchester
(IN BRIEF) A study from the University of Southampton and the University of Bergen reveals that boys who become overweight during their early teens may inadvertently affect the health of their future children. The research found epigenetic changes in genes … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged adolescent obesity, asthma, childhood obesity, DNA methylation, Dr. Negusse Tadesse Kitaba, epigenetics, generational health, health disparities, health inequalities, lung function, Nature Communications Biology, Norwegian Research Council, Obesity, obesity prevention, Professor Cecilie Svanes, Professor John Holloway, public health, RESEARCH, University of Bergen, University of Southampton
(IN BRIEF) A team at the Technical University of Munich has uncovered a potential new explanation for sex-based differences in age-related diseases. Their study found that as female mice age, genes on the silenced second X chromosome become active again. … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged ACE2, age-related diseases, aging, Barr body, cardiovascular disease, Daniel Andergassen, dementia, epigenetics, Nature Aging, neurodegenerative disorders, Parkinson's, Sarah Hoelzl, sex differences, sex-based health differences, Technical University of Munich, TLR8, TUM, X chromosome
(IN BRIEF) Eckert & Ziegler SE has been awarded the “Best Managed Companies Award” for the second time, a prestigious recognition celebrating excellence in strategy, innovation, culture, and governance. This accolade underscores the company’s continued leadership in supplying isotopes for … Read the full press release
Posted in Awards, Berlin, Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Award, Awards, BDI, Best Managed Companies Award, business excellence, CULTURE, Deloitte Private, Dr Christine Wolter, Dr. Harald Hasselmann, Eckert & Ziegler, Federation of German Industries, finance, Frankfurter Allgemeine Zeitung, Governance, INNOVATION, isotopes, leadership, measurement technology, nuclear medicine, STRATEGY, UBS
(IN BRIEF) Samaritans Ireland’s 2024 Impact Report highlights the vital role the charity plays in offering emotional support, with volunteers answering 50 calls per hour on average last year. The report reveals that Samaritans is the only form of support … Read the full press release
Posted in Business, Healthcare, Industrial, Ireland, Management, News, Non Profit, Society
Tagged 116 123, emotional support, family issues, helpline, HSE, Ireland, isolation, loneliness, Mary Butler, mental health, National Office of Suicide Prevention, RESEARCH, Samaritans Ireland, Sarah O'Toole, suicide prevention, University College Cork, volunteering
(IN BRIEF) CVC Strategic Opportunities II has successfully exited its investment in Genetic S.p.A., a pharmaceutical CDMO specializing in Respiratory, Ophthalmic, and Oncology therapeutic products. The exit sees NB Renaissance and NB Aurora joining the Pavese family as shareholders. Under … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Italy, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged CVC Strategic Opportunities II, exit, FRM Tax, Genetic S.p.A., international expansion, investment, NB Aurora, NB Renaissance, oncology, Ophthalmic, partnership, Pavese family, PedersoliGattai, pharmaceutical CDMO, pharmaceutical industry, Product Development, PwC, respiratory, Rocco Pavese, Rothschild & Co., strategic growth
(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
(IN BRIEF) NIB has financed the Gene Therapy Centre in Lithuania, a groundbreaking facility advancing gene therapy research and manufacturing. Opened in September, it is a critical part of Lithuania’s life sciences sector, contributing to the country’s goal of growing … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Lithuania, Management, News, Pharma & Biotech, Science, Technology
Tagged BIO CITY, biotechnology, Celltechna, economic growth, gene therapy, Gene Therapy Centre, investments, life sciences, Lithuania, NIB, Nordic-Baltic region, partnership, research and manufacturing, strategic partnerships, sustainability
(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release
Posted in Business, Chemicals, Environment, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged 2’-fucosyllactose, BENEO, biotechnology, Early Life Nutrition, gut microbiota, HMO, Human Milk Oligosaccharides, immune system, infant formula, Market Growth, partnership, prebiotics, Precision Fermentation, strategic partnership, sustainability, WACKER
(IN BRIEF) GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Blenrep combinations to treat adults with relapsed or refractory multiple myeloma. The approval follows positive results from the DREAMM-7 and DREAMM-8 phase III trials, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged anti-BCMA, antibody-drug conjugate, Blenrep, bortezomib, chemotherapy, clinical efficacy, clinical trials, DREAMM-7, DREAMM-8, global markets, GSK, Japan approval, Multiple Myeloma, oncology, orphan drug designation, overall survival, partnership, PDUFA, pomalidomide, progression-free survival, regulatory approval, sustainability, treatment options
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?